biospecimen_aliquot__bcr_aliquot_barcode	tcga-e2-a158-01a-11d-a12b-09
biospecimen_aliquot__bcr_aliquot_uuid	5517dcca-46e7-4d0c-ba4f-193343f590d6
biospecimen_aliquot__bcr_patient_uuid	a6edb6ca-ae9f-4da7-8ebe-92d83d2987fb
biospecimen_aliquot__bcr_sample_barcode	tcga-e2-a158-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0099017218
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.08
biospecimen_aliquot__date_of_shipment	2011-02-08
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	5
biospecimen_aliquot__plate_id	a12b
biospecimen_aliquot__plate_row	a
biospecimen_aliquot__quantity	6.40
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	80.00
biospecimen_analyte__a260_a280_ratio	1.95
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-e2-a158-01a-11d
biospecimen_analyte__bcr_analyte_uuid	e7bffaf6-1b8d-4a8d-8d1a-097bf5fcaae1
biospecimen_analyte__bcr_patient_uuid	a6edb6ca-ae9f-4da7-8ebe-92d83d2987fb
biospecimen_analyte__bcr_sample_barcode	tcga-e2-a158-01a
biospecimen_analyte__concentration	0.16
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	uv spec
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-e2-a158
biospecimen_diagnostic_slides__bcr_patient_uuid	a6edb6ca-ae9f-4da7-8ebe-92d83d2987fb
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-e2-a158-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	994c60fe-e651-4224-95e7-4669834f2338
biospecimen_normal_control__bcr_patient_barcode	tcga-e2-a158
biospecimen_normal_control__bcr_patient_uuid	a6edb6ca-ae9f-4da7-8ebe-92d83d2987fb
biospecimen_normal_control__ncedna_dna_conc	0.399
biospecimen_normal_control__ncedna_dna_qm	picogreen
biospecimen_normal_control__ncedna_dna_qty	20
biospecimen_normal_control__ncedna_dna_vol	51
biospecimen_normal_control__normal_tissue_anatomic_site	other
biospecimen_portion__bcr_patient_uuid	a6edb6ca-ae9f-4da7-8ebe-92d83d2987fb
biospecimen_portion__bcr_portion_barcode	tcga-e2-a158-01a-11
biospecimen_portion__bcr_portion_uuid	9c943310-dd32-4507-965e-7dbb96b52ca9
biospecimen_portion__bcr_sample_barcode	tcga-e2-a158-01a
biospecimen_portion__date_of_creation	2010-12-21
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	11
biospecimen_portion__portion_sequence	1
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-e2-a158-01a-11d
biospecimen_protocol__bcr_patient_uuid	a6edb6ca-ae9f-4da7-8ebe-92d83d2987fb
biospecimen_protocol__bcr_sample_barcode	tcga-e2-a158-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	a6edb6ca-ae9f-4da7-8ebe-92d83d2987fb
biospecimen_sample__bcr_sample_barcode	tcga-e2-a158-01a
biospecimen_sample__bcr_sample_uuid	5ce91cce-a4ac-45e1-bc3e-737494a67769
biospecimen_sample__days_to_collection	436
biospecimen_sample__initial_weight	200
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	false
biospecimen_sample__pathology_report_file_name	tcga-e2-a158.1cebf20d-767a-4a19-aa41-b9eafcf05176.pdf
biospecimen_sample__pathology_report_uuid	1cebf20d-767a-4a19-aa41-b9eafcf05176
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_shipment_portion__bcr_patient_uuid	a6edb6ca-ae9f-4da7-8ebe-92d83d2987fb
biospecimen_shipment_portion__bcr_sample_barcode	tcga-e2-a158-01a
biospecimen_shipment_portion__bcr_shipment_portion_uuid	b1864b5a-73a3-42f7-b079-30fd70ec3136
biospecimen_shipment_portion__center_id	30
biospecimen_shipment_portion__is_ffpe	no
biospecimen_shipment_portion__plate_id	a21w
biospecimen_shipment_portion__portion_number	31
biospecimen_shipment_portion__portion_sequence	3
biospecimen_shipment_portion__shipment_portion_bcr_aliquot_barcode	tcga-e2-a158-01a-31-a21w-30
biospecimen_shipment_portion__shipment_portion_day_of_shipment	3
biospecimen_shipment_portion__shipment_portion_month_of_shipment	4
biospecimen_shipment_portion__shipment_portion_year_of_shipment	2012
biospecimen_slide__bcr_patient_uuid	a6edb6ca-ae9f-4da7-8ebe-92d83d2987fb
biospecimen_slide__bcr_sample_barcode	tcga-e2-a158-01a
biospecimen_slide__bcr_slide_barcode	tcga-e2-a158-01a-01-ts1
biospecimen_slide__bcr_slide_uuid	7dc3c147-bcdb-4e14-83ef-71e24102846a
biospecimen_slide__image_file_name	tcga-e2-a158-01a-01-ts1.7dc3c147-bcdb-4e14-83ef-71e24102846a.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	2
biospecimen_slide__percent_monocyte_infiltration	1
biospecimen_slide__percent_necrosis	3
biospecimen_slide__percent_neutrophil_infiltration	1
biospecimen_slide__percent_normal_cells	0
biospecimen_slide__percent_stromal_cells	17
biospecimen_slide__percent_tumor_cells	80
biospecimen_slide__percent_tumor_nuclei	80
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-e2-a158
biospecimen_tumor_sample__bcr_patient_uuid	a6edb6ca-ae9f-4da7-8ebe-92d83d2987fb
clinical_drug__bcr_drug_barcode	tcga-e2-a158-d18960
clinical_drug__bcr_drug_uuid	8c16f7b2-efbc-4b7e-aa40-8a152d0e4f0f
clinical_drug__bcr_patient_barcode	tcga-e2-a158
clinical_drug__bcr_patient_uuid	a6edb6ca-ae9f-4da7-8ebe-92d83d2987fb
clinical_drug__form_completion_date	2011-11-8
clinical_drug__pharmaceutical_therapy_drug_name	cytoxan
clinical_drug__pharmaceutical_therapy_type	chemotherapy
clinical_drug__pharmaceutical_tx_ended_days_to	228
clinical_drug__pharmaceutical_tx_ongoing_indicator	no
clinical_drug__regimen_number	1
clinical_drug__therapy_regimen	adjuvant
clinical_follow_up__bcr_followup_barcode	tcga-e2-a158-f18956
clinical_follow_up__bcr_followup_uuid	24e85cd5-eec3-42fe-a66b-6a8dee474b14
clinical_follow_up__bcr_patient_barcode	tcga-e2-a158
clinical_follow_up__bcr_patient_uuid	a6edb6ca-ae9f-4da7-8ebe-92d83d2987fb
clinical_follow_up__followup_reason	scheduled follow-up submission
clinical_follow_up__form_completion_date	2011-11-8
clinical_follow_up__last_contact_days_to	450
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__radiation_treatment_adjuvant	no
clinical_follow_up__targeted_molecular_therapy	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_omf__bcr_omf_barcode	tcga-e2-a158-o10800
clinical_omf__bcr_omf_uuid	04db4c19-b887-438d-9193-64f9613de9bc
clinical_omf__bcr_patient_barcode	tcga-e2-a158
clinical_omf__bcr_patient_uuid	a6edb6ca-ae9f-4da7-8ebe-92d83d2987fb
clinical_omf__days_to_surgical_resection	0
clinical_omf__drug_tx_indicator	no
clinical_omf__form_completion_date	2011-4-7
clinical_omf__malignancy_type	synchronous malignancy
clinical_omf__other_malignancy_anatomic_site	breast
clinical_omf__other_malignancy_laterality	right
clinical_omf__pathologic_M	m0
clinical_omf__pathologic_N	n0
clinical_omf__pathologic_T	t1c
clinical_omf__pathologic_stage	stage i
clinical_omf__radiation_tx_indicator	no
clinical_omf__system_version	6th
clinical_patient__age_at_diagnosis	43
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n1mi
clinical_patient__ajcc_pathologic_tumor_stage	stage iia
clinical_patient__ajcc_staging_edition	6th
clinical_patient__ajcc_tumor_pathologic_pt	t1c
clinical_patient__anatomic_neoplasm_subdivision	left upper inner quadrant|left upper outer quadrant
clinical_patient__axillary_staging_method	sentinel node biopsy alone
clinical_patient__bcr_patient_barcode	tcga-e2-a158
clinical_patient__bcr_patient_uuid	a6edb6ca-ae9f-4da7-8ebe-92d83d2987fb
clinical_patient__birth_days_to	-15903
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_positivity_method	allred score 0+0 = 0
clinical_patient__er_positivity_scale_other	allred score = 0
clinical_patient__er_status_by_ihc	negative
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__form_completion_date	2011-4-7
clinical_patient__gender	female
clinical_patient__her2_ihc_percent_positive	<10%
clinical_patient__her2_ihc_score	1+
clinical_patient__her2_status_by_ihc	negative
clinical_patient__histological_type	infiltrating ductal carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	yes
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8500/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2009
clinical_patient__last_contact_days_to	450
clinical_patient__lymph_nodes_examined	yes
clinical_patient__lymph_nodes_examined_count	2
clinical_patient__lymph_nodes_examined_he_count	1
clinical_patient__margin_status	negative
clinical_patient__menopause_status	pre (<6 months since lmp and no prior bilateral ovariectomy and not on estrogen replacement)
clinical_patient__metastatic_tumor_indicator	no
clinical_patient__method_initial_path_dx	tumor resection
clinical_patient__micromet_detection_by_ihc	no
clinical_patient__patient_id	a158
clinical_patient__pr_positivity_define_method	allred score 0+0 = 0
clinical_patient__pr_positivity_scale_other	allred score = 0
clinical_patient__pr_status_by_ihc	negative
clinical_patient__prospective_collection	no
clinical_patient__race	white
clinical_patient__retrospective_collection	yes
clinical_patient__surgical_procedure_first	simple mastectomy
clinical_patient__tissue_source_site	e2
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-E2-A158-01A-11D-A12B-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-E2-A158-01A-11D-A12B-09.bed.meta
manually_curated__id	tcga-e2-a158-01a-11d-a12b-09
manually_curated__md5sum	c67527d5bbb27b340d81587717e8c486
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	5517dcca-46e7-4d0c-ba4f-193343f590d6
manually_curated__tumor_tag	brca
